Lan Yang

2.1k total citations · 1 hit paper
57 papers, 1.6k citations indexed

About

Lan Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lan Yang has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 19 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Lan Yang's work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (9 papers) and MicroRNA in disease regulation (8 papers). Lan Yang is often cited by papers focused on RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (9 papers) and MicroRNA in disease regulation (8 papers). Lan Yang collaborates with scholars based in China, United States and United Kingdom. Lan Yang's co-authors include Michael R. Stallcup, Heng Hong, Jianming Hu, Xiaobin Cui, Yunzhao Chen, Donald Defranco, Hao Peng, Hong Zhou, Dandan Wang and Jun Li and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Lan Yang

52 papers receiving 1.5k citations

Hit Papers

Epigenetically upregulated oncoprotein PLCE1 drives esoph... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression
    2019 306 citations Yunzhao Chen, Dandan Wang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Yang China 20 1.0k 435 319 270 230 57 1.6k
Weiwei Li China 21 959 0.9× 380 0.9× 200 0.6× 218 0.8× 118 0.5× 72 1.5k
Christopher Albanese United States 23 818 0.8× 263 0.6× 213 0.7× 481 1.8× 157 0.7× 51 1.7k
Kyung Hyun Yoo South Korea 22 1.3k 1.2× 297 0.7× 355 1.1× 246 0.9× 142 0.6× 70 1.7k
Ken‐ichi Kozaki Japan 21 906 0.9× 357 0.8× 182 0.6× 312 1.2× 134 0.6× 34 1.5k
Fang Zhao China 18 762 0.7× 365 0.8× 178 0.6× 217 0.8× 161 0.7× 44 1.4k
Hui Zeng China 21 929 0.9× 324 0.7× 127 0.4× 228 0.8× 140 0.6× 81 1.4k
Yan Jin China 23 773 0.8× 309 0.7× 153 0.5× 262 1.0× 219 1.0× 74 1.3k

Countries citing papers authored by Lan Yang

Since Specialization
Citations

This map shows the geographic impact of Lan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Yang more than expected).

Fields of papers citing papers by Lan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Yang. The network helps show where Lan Yang may publish in the future.

Co-authorship network of co-authors of Lan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Yang. A scholar is included among the top collaborators of Lan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Yang. Lan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Miaomiao, Yi Wang, Xinyan Li, et al.. (2025). Pharmacological targeting of the mitochondrial phosphatase PTPMT1 sensitizes hepatocellular carcinoma to ferroptosis. Cell Death and Disease. 16(1). 257–257. 4 indexed citations
2.
Wang, Yali, et al.. (2024). Deguelin and Paclitaxel Loaded PEG-PCL Nano-Micelles for Suppressing the Proliferation and Inducing Apoptosis of Breast Cancer Cells. Frontiers in Bioscience-Landmark. 29(2). 90–90. 4 indexed citations
3.
Gao, Zhaowei, Lan Yang, Chong Liu, et al.. (2022). Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis. Frontiers in Immunology. 13. 903461–903461. 18 indexed citations
4.
Yang, Bo, Bin Zhang, Zhifei Cao, et al.. (2020). Correction: The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapy. Cell Death and Differentiation. 27(9). 2746–2746. 1 indexed citations
5.
Wang, Shasha, et al.. (2019). Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma. Molecular Omics. 15(1). 88–100. 8 indexed citations
6.
Gao, Wan-Feng, Xiaoyun Zhang, Heng Zhang, et al.. (2019). Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells. Journal for ImmunoTherapy of Cancer. 7(1). 231–231. 44 indexed citations
7.
Chen, Yunzhao, Dandan Wang, Hao Peng, et al.. (2019). Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression. Molecular Cancer. 18(1). 1–1. 306 indexed citations breakdown →
8.
Zhang, Yi, Beifang Yang, Xiang Cheng, et al.. (2018). Integrative functional genomics identifies regulatory genetic variant modulating RAB31 expression and altering susceptibility to breast cancer. Molecular Carcinogenesis. 57(12). 1845–1854. 1 indexed citations
9.
Lu, Mudan, Xuan Chen, Jianping Xiao, et al.. (2018). FOXO3a Reverses the Cisplatin Resistance in Ovarian Cancer. Archives of Medical Research. 49(2). 84–88. 15 indexed citations
10.
Chen, Yalan, Lan Yang, Haiyan Hu, Jiajia Chen, & Bairong Shen. (2017). How to Become a Smart Patient in the Era of Precision Medicine?. Advances in experimental medicine and biology. 1028. 1–16. 14 indexed citations
11.
Xiao, Jianping, Tao Tao, Yongxiang Yin, et al.. (2017). miR-144 may regulate the proliferation, migration and invasion of trophoblastic cells through targeting PTEN in preeclampsia. Biomedicine & Pharmacotherapy. 94. 341–353. 57 indexed citations
12.
Yang, Lan, Ling Chen, Tingting Li, et al.. (2015). Heterozygote of TAP1 Codon637 decreases susceptibility to HPV infection but increases susceptibility to esophageal cancer among the Kazakh populations. Journal of Experimental & Clinical Cancer Research. 34(1). 70–70. 19 indexed citations
13.
Ma, Yiming, et al.. (2015). The Regulation of miRNAs in Inflammation-Related Carcinogenesis. Current Pharmaceutical Design. 21(21). 3023–3031. 7 indexed citations
14.
Yang, Lan, Liyun Zheng, Ye Tian, et al.. (2015). C6 ceramide dramatically enhances docetaxel-induced growth inhibition and apoptosis in cultured breast cancer cells: A mechanism study. Experimental Cell Research. 332(1). 47–59. 71 indexed citations
15.
Yang, Lan, Honglin Hu, Ying Deng, & Yifeng Bai. (2014). [Role of SPHK1 regulates multi-drug resistance of small cell lung cancer 
and its clinical significance].. SHILAP Revista de lepidopterología. 17(11). 769–77. 7 indexed citations
16.
17.
Ma, Jian, Yu Qiu, Lan Yang, et al.. (2010). Desipramine induces apoptosis in rat glioma cells via endoplasmic reticulum stress-dependent CHOP pathway. Journal of Neuro-Oncology. 101(1). 41–48. 34 indexed citations
18.
Guerrero‐Santoro, Jennifer, Lan Yang, Michael R. Stallcup, & Donald Defranco. (2004). Distinct LIM domains of Hic‐5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation. Journal of Cellular Biochemistry. 92(4). 810–819. 23 indexed citations
19.
20.
Hong, Heng, Lan Yang, & Michael R. Stallcup. (1999). Hormone-independent Transcriptional Activation and Coactivator Binding by Novel Orphan Nuclear Receptor ERR3. Journal of Biological Chemistry. 274(32). 22618–22626. 255 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiwei Li Breakdown of academic impact, for papers by Christopher Albanese Breakdown of academic impact, for papers by Kyung Hyun Yoo Breakdown of academic impact, for papers by Ken‐ichi Kozaki Breakdown of academic impact, for papers by Fang Zhao Breakdown of academic impact, for papers by Hui Zeng Breakdown of academic impact, for papers by Yan Jin
Rankless by CCL
2026